Journal of Enzyme Inhibition and Medicinal Chemistry (Jan 2021)

Flavonoids as inhibitors of human neutrophil elastase

  • Katarzyna Jakimiuk,
  • Jakub Gesek,
  • Atanas G. Atanasov,
  • Michał Tomczyk

DOI
https://doi.org/10.1080/14756366.2021.1927006
Journal volume & issue
Vol. 36, no. 1
pp. 1016 – 1028

Abstract

Read online

Elastase is a proteolytic enzyme belonging to the family of hydrolases produced by human neutrophils, monocytes, macrophages, and endothelial cells. Human neutrophil elastase is known to play multiple roles in the human body, but an increase in its activity may cause a variety of diseases. Elastase inhibitors may prevent the development of psoriasis, chronic kidney disease, respiratory disorders (including COVID-19), immune disorders, and even cancers. Among polyphenolic compounds, some flavonoids and their derivatives, which are mostly found in herbal plants, have been revealed to influence elastase release and its action on human cells. This review focuses on elastase inhibitors that have been discovered from natural sources and are biochemically characterised as flavonoids. The inhibitory activity on elastase is a characteristic of flavonoid aglycones and their glycoside and methylated, acetylated and hydroxylated derivatives. The presented analysis of structure–activity relationship (SAR) enables the determination of the chemical groups responsible for evoking an inhibitory effect on elastase. Further study especially of the in vivo efficacy and safety of the described natural compounds is of interest in order to gain better understanding of their health-promoting potential.

Keywords